Health Care Counsel Blog
806 total results. Page 3 of 33.
Douglas A. Grimm
No personal services are more important than health care. The use of artificial intelligence (AI), involving machines to perform tasks normally requiring human intelligence, is leading to an expansion of the term “personal.”
Gayland O. Hethcoat II, Mariam Al-Koshnaw Creedon
As more states adopt consumer data privacy laws, Nevada and Washington stand out for their recent passage of legislation aimed specifically at protecting “consumer health data.”
Cissy Jackson, Daniel Sjostedt*
In November of 2022, we predicted a fertile post-election congressional landscape for Pharmacy Benefit Manager (PBM) practice reform.
D. Jacques Smith, Randall A. Brater, Morgan R. Pankow
On June 16, 2023, in United States, ex rel. Polansky v. Executive Health Resources, Inc., the US Supreme Court addressed the government’s authority to dismiss a qui tam False Claims Act (FCA) suit over a relator’s objection when the government initially declines to intervene in the litigation.
Annie Chang Lee, Gayland O. Hethcoat II, M.H. Joshua Chiu
The recently passed Consolidated Appropriations Act (CAA) of 2023 includes a new Stark Law exception and Anti-Kickback Statute (AKS) safe harbor, allowing hospitals and other health care entities to offer their physicians programs to improve mental health and resiliency.
Douglas A. Grimm, Gayland O. Hethcoat II
Telehealth experienced massive growth during the COVID-19 pandemic, due in no small part to various regulatory and reimbursement policies that federal agencies implemented.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Laura Zell, Morgan R. Pankow
Headlines that Matter for Companies and Executives in Regulated Industries
Caroline Turner English, David S. Greenberg, Alison Lima Andersen, D. Austin Rettew
In the year following the implementation of the arbitration process established under the federal No Surprises Act (NSA), more than 330,000 disputes have been submitted for resolution.
Anne M. Murphy, Stephen Blake
Throughout 2021 and 2022, states have been seeking to include or have successfully included medical respite to Medicaid 1115 waivers. These experimental Medicaid-reimbursed programs are reviewed and approved by the Secretary of Health and Human Services to promote the objectives of Medicaid.
Publicizing home health agency and hospice agency ownership information furthers President Biden’s goal to promote competition and make data more transparent for consumers, as noted in his July 2021 Executive Order.
Anne M. Murphy, Stephen Blake
An outcome of the COVID-19 pandemic has been the attractiveness of innovative care alternatives, for patients and providers alike.
D. Jacques Smith, Randall A. Brater, Nadia Patel, Michael F. Dearington, Morgan R. Pankow, Apeksha Vora
Headlines that Matter for Companies and Executives in Regulated Industries
Gayland O. Hethcoat II
On February 17, 2023, the US Department of Health and Human Services Office for Civil Rights (OCR) released two companion reports to Congress detailing its actions in 2021 to enforce the privacy, security, and breach notification requirements under HIPAA.
Anne M. Murphy, Mark A. Angelov, Mike Guippone
Over 2500 hospitals across the country historically have relied upon Disproportionate Share Hospital (DSH) Medicaid payments for financial stability.
Jill A. Steinberg, Anne M. Murphy, Gayland O. Hethcoat II
In the landmark case of Dobbs v. Jackson Women’s Health Organization, the US Supreme Court overturned its prior rulings in Roe v. Wade and Planned Parenthood of Southeastern Pennsylvania v. Casey, which had recognized a constitutional right to abortion protected from government interference.
Jill A. Steinberg, Emily M. Leongini, Hillary M. Stemple, Shoshana Golden
As those in the reproductive health space scramble to keep up with the ever-changing landscape of mifepristone (Mifeprex) access, it seems that every party must have their say.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Mattie Bowden, Heather M. Zimmer
Headlines that Matter for Companies and Executives in Regulated Industries
Anne M. Murphy
Health Care Partner Anne Murphy recently talked with Deborah Biggs of PYA and Michael Peregrine of MWE about recent developments surrounding environmental, social, and corporate governance (ESG) in the health care industry.
Caroline Turner English, Alison Lima Andersen, D. Austin Rettew, Malia K. Benison
In parallel cases, health care providers are continuing to challenge rulemaking by the US Departments of Treasury, Labor, and Health and Human Services (the Departments) under the No Surprises Act (the Act).
Sarah G. Benator
In a move changing a decades-long practice, The Joint Commission extended its required timeframe for the reappointment of practitioners from every two years to every three years, unless law or regulation require shorter time periods.
Michele L. Gipp, Anne M. Murphy, Jill A. Steinberg
On February 15, 2023, the Centers for Medicare & Medicaid Services (CMS) released a proposed rule which would require greater disclosures of the ownership and management of Medicare and Medicaid nursing homes.
The latest edition of a widely circulated annual survey of the national healthcare supply chain has found that healthcare group purchasing organizations (GPOs) are adhering to best business practices, and exploring innovative methods to address supply disruptions while promoting cost savings.
David S. Greenberg, Gayland O. Hethcoat II, Michele L. Gipp, Douglas A. Grimm, Anne M. Murphy, Aphrodite Kokolis, Jack R. Bierig, Brian D. Schneider, Hillary M. Stemple, Stephanie Trunk, Alison Lima Andersen
With the new year underway, the ArentFox Schiff Health Care team highlights 10 of the most pressing legal issues facing the industry in 2023.
Caroline Turner English, Alison Lima Andersen, D. Austin Rettew
On February 6, 2023, health care providers scored a second significant victory when a federal court in Texas again vacated portions of the Biden Administration’s rules governing the arbitration procedures to resolve surprise billing disputes under the federal No Surprises Act (NSA).
Stephanie Trunk
The Centers for Medicare & Medicaid Services (CMS) and the US Department of Health and Human Services Office of Inspector General (OIG) continue to issue guidance regarding the implementation of the drug pricing provisions of the Inflation Reduction Act (IRA).